0.9337USD-0.68%Mkt Cap: 39.24M $P/E: —1d ago
MIRA Pharmaceuticals, Inc. operates as a pre-clinical-stage pharmaceutical development company with two neuroscience programs targeting a range of neurologic and neuropsychiatric disorders. The company holds exclusive U.…
Industry Peers
Drug Manufacturers - GeneralIndicators:|
Key Statistics
Company
Market Cap39.24M $
Enterprise Value29.83M $
Revenue (TTM)—
Gross Profit—
Net Income (TTM)-10.44M $
Revenue/Share—
Last Price0.9337 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees—
CountryUS
SectorHealthcare
IndustryDrug Manufacturers - General
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)-2.28
PEG—
EV/EBITDA—
EV/Revenue—
P/S—
P/B4.21
EPS (TTM)-1.27
EPS (Forward)-0.41
52W Range
0.89612% of range2.450
52W High2.450 USD
52W Low0.8961 USD
Profitability
Gross Margin0.00%
Oper. Margin0.00%
EBITDA Margin0.00%
Profit Margin0.00%
ROE-100.49%
ROA-94.13%
Growth
Revenue Growth—
Earnings Growth—
Cash Flow & Leverage
Operating CF-4.66M $
CapEx (TTM)—
FCF Margin—
FCF Yield-1.09%
Net Debt-9.41M $
Net Debt/EBITDA—
Balance Sheet
Debt/Equity—
Current Ratio82.16
Quick Ratio81.97
Book Value/Sh0.2220 USD
Cash/Share0.2240 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.42.02M
Float35.03M
Insiders16.71%
Institutions5.03%
Short Interest
Short Ratio1.9d
Short % Float0.49%
Short % Out.0.45%
Shares Short189.32K
Short (prev mo.)368.30K
Technical
SMA 500.9772 (-4.5%)
SMA 2001.233 (-24.3%)
Beta1.49
S&P 52W Chg20.25%
Avg Vol (30d)84.24K
Avg Vol (10d)46.82K
Technical Indicators
RSI (14)46.3
MACD-0.0162
MACD Signal-0.0171
MACD Hist.+0.0009
BB Upper0.9919 USD
BB Middle0.9422 USD
BB Lower0.8924 USD
BB Width10.56%
ATR (14)0.0528 USD
Vol Ratio (20d)2.57x